Open the mobile version, with barcode scanning
Class II Ongoing

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,…

Why: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Company
Cipla USA, Inc.
Warren, NJ, United States
Reported
Apr 22, 2026
Recall started
Mar 16, 2026
Where sold
Nationwide in the USA
Amount
113,336 bottles
Full product description
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
Lots / codes affected
Lot, expiry: Lot 4PB0526, 4PB0527, 4PB0528, exp September-2026; Lot 5PB0173, exp January-2027

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.